Inspire Medical Systems appoints AtriCure CEO Michael Carrel to board
INSP•Board appointment announced
- Inspire Medical Systems appointed Michael H. Carrel to its board, effective July 20.
- Carrel has been president, CEO, and a director of AtriCure since November 2012.
- He previously served as chairman of Axonics from 2019 to 2024, ending with its sale to Boston Scientific.
- AtriCure revenue rose to USD 535 million in 2025 from USD 82 million in 2013 during his tenure.




